# ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES.

> **NIH NIH N43** · INTEGRAL MOLECULAR · 2022 · $600,000

## Abstract

Using their unique Membrane Proteome Array (MPA)technology, the contractor will screen a comprehensive library of human cell surface proteins to identify novel immunomodulatory targets that regulate dendritic cell or Toll-like receptor (TLR) activation.

## Key facts

- **NIH application ID:** 10678504
- **Project number:** 75N93022C00032-0-9999-1
- **Recipient organization:** INTEGRAL MOLECULAR
- **Principal Investigator:** JOSEPH RUCKER
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $600,000
- **Award type:** —
- **Project period:** 2022-06-30 → 2024-06-29

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10678504

## Citation

> US National Institutes of Health, RePORTER application 10678504, ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES. (75N93022C00032-0-9999-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10678504. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*